GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced BioMedical Technologies Inc (OTCPK:ABMT) » Definitions » Operating Margin %

Advanced BioMedical Technologies (Advanced BioMedical Technologies) Operating Margin % : 0.00% (As of Jul. 2021)


View and export this data going back to 2007. Start your Free Trial

What is Advanced BioMedical Technologies Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Advanced BioMedical Technologies's Operating Income for the three months ended in Jul. 2021 was $-0.11 Mil. Advanced BioMedical Technologies's Revenue for the three months ended in Jul. 2021 was $0.00 Mil. Therefore, Advanced BioMedical Technologies's Operating Margin % for the quarter that ended in Jul. 2021 was 0.00%.

The historical rank and industry rank for Advanced BioMedical Technologies's Operating Margin % or its related term are showing as below:


ABMT's Operating Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.28
* Ranked among companies with meaningful Operating Margin % only.

Advanced BioMedical Technologies's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Advanced BioMedical Technologies's Operating Income for the three months ended in Jul. 2021 was $-0.11 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jul. 2021 was $-0.42 Mil.


Advanced BioMedical Technologies Operating Margin % Historical Data

The historical data trend for Advanced BioMedical Technologies's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced BioMedical Technologies Operating Margin % Chart

Advanced BioMedical Technologies Annual Data
Trend Oct11 Oct12 Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -5,041.67 -258.87

Advanced BioMedical Technologies Quarterly Data
Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11,700.00 -177.42 -189.36 - -

Competitive Comparison of Advanced BioMedical Technologies's Operating Margin %

For the Medical Devices subindustry, Advanced BioMedical Technologies's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced BioMedical Technologies's Operating Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced BioMedical Technologies's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Advanced BioMedical Technologies's Operating Margin % falls into.



Advanced BioMedical Technologies Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Advanced BioMedical Technologies's Operating Margin % for the fiscal year that ended in Oct. 2020 is calculated as

Operating Margin %=Operating Income (A: Oct. 2020 ) / Revenue (A: Oct. 2020 )
=-0.321 / 0.124
=-258.87 %

Advanced BioMedical Technologies's Operating Margin % for the quarter that ended in Jul. 2021 is calculated as

Operating Margin %=Operating Income (Q: Jul. 2021 ) / Revenue (Q: Jul. 2021 )
=-0.112 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Advanced BioMedical Technologies  (OTCPK:ABMT) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Advanced BioMedical Technologies Operating Margin % Related Terms

Thank you for viewing the detailed overview of Advanced BioMedical Technologies's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Advanced BioMedical Technologies (Advanced BioMedical Technologies) Business Description

Traded in Other Exchanges
N/A
Address
200 Park Avenue, Suite 1700, New York, NY, USA, 10166
Advanced BioMedical Technologies Inc is engaged in designing, developing, manufacturing, and the planned future marketing of self-reinforced, re-absorbable biodegradable internal fixation devices. The company manufactures its products using Polyamide, and it is used in a variety of applications, which include orthopaedic trauma, sports-related medical treatment, cartilage injuries, and reconstructive dental procedures. Its Polyamide products include screws, rods, and binding wires consisting of enhanced fibres and high molecular polymers, which are designed to facilitate quick healing of complex fractures in many areas of the human skeletal system.
Executives
Advanced Biomedical Technologies Inc. director, officer: CFO 200 PARK AVENUE, SUITE 1700 NEW YORK NY 10166
Lynch John Thomas Jr other: Advisor 22 MULBERRY STREET SUITE 1B MIDDLETOWN NY 10940
Chi Ming Yu director, 10 percent owner, officer: PRESIDENT 36 CLAREMONT TERRACE WAYNE NJ 07470
Andriy Protskiv director, 10 percent owner, officer: President, CEO, CFO 706-15038 101 AVENUE SURREY A1 V3R 0N2

Advanced BioMedical Technologies (Advanced BioMedical Technologies) Headlines